Finance

Lists
BBOT:NASDAQ
BridgeBio Oncology Therapeutics Inc
၃.၂၆ US$
-၁.၅၁%
(-၀.၀၅၀) 1D
၃.၂၆ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၂, GMT-၄ ၁၆:၀၀:၀၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBOT...
Open
၃.၃၁ US$
High
၃.၃၇ US$
Low
၃.၂၃ US$
Mkt. cap
၂၆.၁၄ ကုဋေ
Avg. vol.
၆.၇၆ သိန်း
Volume
၀.၀၀
52-wk high
၁၄.၈၇ US$
52-wk low
၃.၂၃ US$
EPS
-၃.၀၄ US$
Shares outstanding
၈.၀၂ ကုဋေ
No. of employees
၈၈
Open
၃.၃၁ US$
High
၃.၃၇ US$
Low
၃.၂၃ US$
Mkt. cap
၂၆.၁၄ ကုဋေ
Avg. vol.
၆.၇၆ သိန်း
Volume
၀.၀၀
52-wk high
၁၄.၈၇ US$
52-wk low
၃.၂၃ US$
EPS
-၃.၀၄ US$
Shares outstanding
၈.၀၂ ကုဋေ
No. of employees
၈၈
News stories
From web sources and news partners
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com
About BridgeBio Oncology Therapeutics Inc
CEO-
Employees၈၈
Founded၂၀၁၆
HeadquartersSouth San Francisco, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitebbotx.com
Analyst ratings
Based on 9 analysts giving stock ratings to BBOT in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for BBOT in the last 3 months.
Highest
Current ၃.၂၆ US$
၂၅.၀၀ US$ (+၆၆၆.၈၇%)
Average
၂၁.၀၀ US$ (+၅၄၄.၁၇%)
Lowest
၁၅.၀၀ US$ (+၃၆၀.၁၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Berens
Leerink Partners
Buy
Reiterated
၂၅.၀၀ US$
+၆၆၆.၉%
09/18/2026
Priyanka Grover
J.P. Morgan
Buy
Reiterated
-
-
09/15/2026
Unknown Analyst
Wedbush
Buy
Maintained
၂၅.၀၀ US$
+၆၆၆.၉%
09/09/2026
Biren Amin
Piper Sandler
Buy
Maintained
၂၁.၀၀ US$
+၅၄၄.၂%
09/09/2026
Sean McCutcheon
Raymond James
Buy
Maintained
၂၂.၀၀ US$
+၅၇၄.၈%
09/09/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
၁၅.၀၀ US$
+၃၆၀.၁%
09/09/2026
John Newman
Canaccord Genuity
Buy
Maintained
၂၀.၀၀ US$
+၅၁၃.၅%
09/09/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
၁၈.၀၀ US$
+၄၅၂.၁%
08/17/2026
Unknown Analyst
J.P. Morgan
Buy
Reiterated
၂၅.၀၀ US$
+၆၆၆.၉%
08/14/2026
Mazahir Alimohamed
Oppenheimer
Buy
Reiterated
၂၂.၀၀ US$
+၅၇၄.၈%
08/12/2026
David Nierengarten
Wedbush
Buy
Maintained
၂၅.၀၀ US$
+၆၆၆.၉%
05/13/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
၂၂.၀၀ US$
+၅၇၄.၈%
05/13/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၂၉.၀၀ US$
+၇၈၉.၆%
05/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၃.၅၁ ကုဋေ
၃.၈၁ ကုဋေ
၃.၉၈ ကုဋေ
၄.၉၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၄၁ ကုဋေ
၅.၃၃ သန်း
၆.၃၈ သန်း
၁.၁၀ ကုဋေ
Operating expense
၄.၉၂ ကုဋေ
၄.၃၄ ကုဋေ
၄.၆၂ ကုဋေ
၆.၀၂ ကုဋေ
Total operating expenses
၄.၉၂ ကုဋေ
၄.၃၄ ကုဋေ
၄.၆၂ ကုဋေ
၆.၀၂ ကုဋေ
Operating income
-၄.၉၂ ကုဋေ
-၄.၃၄ ကုဋေ
-၄.၆၂ ကုဋေ
-၆.၀၂ ကုဋေ
Other non operating income
၉.၈၀ သိန်း
၁.၈၇ သိန်း
၁.၂၉ သိန်း
၁.၈၂ သိန်း
EBT including unusual items
-၄.၄၈ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၂၁ ကုဋေ
-၅.၆၅ ကုဋေ
EBT excluding unusual items
-၄.၄၈ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၂၁ ကုဋေ
-၅.၆၅ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၄.၄၈ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၂၁ ကုဋေ
-၅.၆၅ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၁.၀၃
-၀.၄၉
-၀.၅၃
-၀.၇၁
Interest and investment income
၃.၄၄ သန်း
၄.၄၂ သန်း
၃.၉၄ သန်း
၃.၅၅ သန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၄၄ သန်း
၄.၄၂ သန်း
၃.၉၄ သန်း
၃.၅၅ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၉၁ ကုဋေ
-၄.၃၃ ကုဋေ
-၄.၆၁ ကုဋေ
-၆.၀၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ